Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akorn Inc (NASDAQ:AKRX)

30.16
Delayed Data
As of May 27
 +0.41 / +1.38%
Today’s Change
17.57
Today|||52-Week Range
48.53
-19.16%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Medical Distributors
MARKET CAP
$3.6B

Company Description

Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. It specializes in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The company markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. It operates through the following segments: Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter OTC products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.

Contact Information

Akorn, Inc.
1925 West Field Court
Lake Forest Illinois 60045-4862
P:(847) 279-6100
Investor Relations:
(847) 582-6923

Employees

Shareholders

Other institutional48.10%
Individual stakeholders43.75%
Mutual fund holders34.08%

Top Executives

Raj RaiChief Executive Officer
Bruce KutinskyChief Operating Officer
Duane A. PortwoodChief Financial Officer & Executive Vice President
Mark M. SilverbergExecutive VP-Operations & Technical Services
Joseph P. BonaccorsiSecretary, Senior Vice President & General Counsel